Q: I have noted in the past that quarterly MD&A's have included a breakdown of revenue for each dispensary, both for the quarter and in comparison to the same period of the previous year. Recently, this specific information has become absent in quarterly reporting and dispensary revenues have been lumped together. The company response was they made the change for competitive reasons???
I have two questions which I'd be grateful to have answered.
1) Why has the company chosen to omit this information in recent reporting? The limited number of dispensaries currently operating, though growing, does not make this an onerous task.
2) Where can I access revenue per individual dispensary?
Q: good day. I purchased MX about 6 months ago. It represents 1.5% of my portfolio. It's dropped about 19% since purchasing. I'd like your advice on whether I should add, hold or sell this position in favour of another stock in the sector. if the answer is sell, what could I replace it with? Thanks
Q: For a company with a $40 million market cap, Q4 results seem quite compelling with cash flow generation being very strong and debt declining. What does 5i think of fiscal 2021 results in relation to the current stock price of Avante Logixx?
Q: At the time of writing this, BEPC is trading at $50.66 and BEP.UN at $47.49.......their corresponding 52 week highs are $80.30 and $63.39 which means that BEPC is 58.5% off its high and BEP.UN is 33.5% off its market high. First blush would suggest that BEPC may have a much greater upside from here but that of course relies entirely on what the market determines is a fair premium for BEPC. Currently that premium has dropped to 6.7% . Do you feel that this is too low, too high or just about right??
Q: Albright has been appointed to the board and taken a nice size position. I seem to recall his name in other companies going back a number of years. What is his reputation on the street?
Reading your response to one of our 5i members' question about "POAHY" which is listed in US ADR market, you mentioned ADRs can have more risks itself. Could you please elaborate more about the risks associated with ADRs.
Q: Is this the season for owning Biotech stocks , if so, which ones do you favour ? ...
Am I just better off owning stocks, ETFs , or the spider .
I have never done well in that subsection, so I am hesitant .
Q: Assuming gold holds above $1750, do you think Barrick's dividend is safe? Because, if so, a 4% plus dividend yield is very attractive while waiting for price appreciation. Thank you.
Q: On July 3 , Motley Fool stated that " the team has confirmed that the company could be acquired by the management itself. The leadership team has partnered with a group to bid " It closed at around $ 47 that day. Today it is $ 44.56 . Reason ? Thanks a million.
Q: Hi 5i,
In your answer to Andrew this morning, of the companies he proposed you did not name EGLX as one of your top 3 choices for a TFSA. I'm not sure if this represents a downgrade in your opinion of EGLX...?
What are your current thoughts about EGLX and is there anything to be leery of at present that wasn't a concern a month or so ago when, if memory serves me, you were fairly bullish on the stock?
Thanks,
Peter
Q: Looking for suggestions to add to current holdings in the following sectors:
Real Estate -
Utilities - have BEPC
Materials - have SJ
Energy - have ENB
Communication Services - have GOOG
Industrial - have TFII, SIS, XBC, KBL
Consumer Staple - have ATD.B, PBH
Health care - have WELL, GUD
Q: My young grandson has $450 to invest. I have agreed to purchase the stock (s) in a non registered account. Long term hold. I'm picking up the trading cost. Suggested a stock (s) that trades under $10. Can you recommend one or two stocks to consider. This is more of a learning exercise for him. Thanks for your wonderful service.
Q: Hi,
In Eddy Elfenbein's latest CWS Market Review, he mentions Mueller Industries as a great company that gets almost no coverage. I didn't find any previous questions on MLI here.
From my limited sources, it seems to have a low P/E and relatively low debt, and a high margin between earnings and dividend payouts. Earnings growth this year looks excellent and next year not bad.
What's your take on the company? Does it look like a good long-term investment? Thank you. Michael
Q: Faced with a breath-taking loss in the shares of this barking hound,
I'm thinking that even though it has had a very short existence, it might
be wise to dump it now before tax-loss selling seems likely to crush it
completely in the coming months and maybe turn it into a penny stock.
What say you? Thanks in advance for your thoughts.